(Q37534910)
Statements
1 reference
Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2. (English)
1 reference
Gabriel N Hortobagyi
1 reference
Hope S Rugo
1 reference
Norikazu Masuda
1 reference
J Thaddeus Beck
1 reference
Mario Campone
1 reference
Fabienne Lebrun
1 reference
Ines Deleu
1 reference
Barbara Pistilli
1 reference
Lowell Hart
1 reference
Bohuslav Melichar
1 reference
Shaker Dakhil
1 reference
Matthias Geberth
1 reference
Martina Nunzi
1 reference
Daniel Y C Heng
1 reference
Thomas Brechenmacher
1 reference
Mona El-Hashimy
1 reference
Shyanne Douma
1 reference
Francois Ringeisen
1 reference
Martine Piccart
1 reference
21 December 2013
1 reference
1 reference
459-467
1 reference
21 December 2013
1 reference
Identifiers
1 reference
1 reference
1 reference